The North America Clinical Oncology Next Generation Sequencing (NGS) market is playing a pivotal role in advancing precision oncology by enabling faster, more accurate, and comprehensive genomic profiling for cancer diagnosis and treatment selection. The United States remains at the forefront of regional growth, supported by a well-established healthcare infrastructure, increasing adoption of...